TheraRadar
Data updated: Mar 29, 2026

HYDROXYZINE PAMOATE

HYDROXYZINE PAMOATE
Neurology Approved 1981-12-14

Hydroxyzine pamoate is indicated for the symptomatic relief of anxiety and tension associated with psychoneurosis or as an adjunct in organic disease states where anxiety manifests. It is also indicated for the management of pruritus due to allergic conditions, including chronic urticaria, atopic and contact dermatoses, and histamine-mediated pruritus. Additionally, it is used as a sedative for premedication and following general anesthesia. The effectiveness of hydroxyzine for long-term use (exceeding 4 months) has not been systematically evaluated; therefore, its usefulness should be reassessed periodically for individual patients.

Source: FDA Label • Novartis

How HYDROXYZINE PAMOATE Works

Hydroxyzine is a first-generation antihistamine that acts as a potent H1-receptor inverse agonist. Its anxiolytic and sedative properties are attributed to its activity in the subcortical regions of the central nervous system, specifically the limbic system and reticular formation, rather than the cerebral cortex. Unlike many other anxiolytics, it does not possess affinity for GABA receptors. Additionally, hydroxyzine exhibits antagonistic effects at 5-HT2A, D2, and α1-adrenergic receptors, which may contribute to its clinical profile. It also possesses anticholinergic and antiemetic properties.

Source: FDA Label
13
Indications
--
Phase 3 Trials
44
Years on Market

HYDROXYZINE PAMOATE Approval History

Loading approval history...

What HYDROXYZINE PAMOATE Treats

6 indications

HYDROXYZINE PAMOATE is approved for 6 conditions since its original approval in 1981. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Anxiety
  • Psychoneurosis
  • Pruritus
  • Urticaria
  • Atopic Dermatitis
  • Contact Dermatitis
Source: FDA Label

Drugs Similar to HYDROXYZINE PAMOATE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
BETAMETHASONE ACETATE
2 shared
Hikma
Shared indications:
Atopic DermatitisContact Dermatitis
CELESTONE SOLUSPAN
BETAMETHASONE ACETATE
2 shared
Merck
Shared indications:
Atopic DermatitisContact Dermatitis
DEPO-MEDROL
METHYLPREDNISOLONE ACETATE
2 shared
Pfizer
Shared indications:
Atopic DermatitisContact Dermatitis
DEXAMETHASONE
DEXAMETHASONE
2 shared
ALVOGEN
Shared indications:
Atopic DermatitisContact Dermatitis
DEXAMETHASONE INTENSOL
DEXAMETHASONE
2 shared
Hikma
Shared indications:
Atopic DermatitisContact Dermatitis
DEXYCU KIT
DEXAMETHASONE
2 shared
EYEPOINT PHARMS
Shared indications:
Atopic DermatitisContact Dermatitis
KENALOG-40
TRIAMCINOLONE ACETONIDE
2 shared
APOTHECON
Shared indications:
Atopic DermatitisContact Dermatitis
METHYLPREDNISOLONE ACETATE
METHYLPREDNISOLONE ACETATE
2 shared
SAGENT PHARMS INC
Shared indications:
Atopic DermatitisContact Dermatitis
ORAPRED ODT
PREDNISOLONE SODIUM PHOSPHATE
2 shared
ADVANZ PHARMA
Shared indications:
Atopic DermatitisContact Dermatitis
PEDIAPRED
PREDNISOLONE SODIUM PHOSPHATE
2 shared
SETON PHARM
Shared indications:
Contact DermatitisAtopic Dermatitis
SOLU-CORTEF
HYDROCORTISONE SODIUM SUCCINATE
2 shared
PHARMACIA AND UPJOHN
Shared indications:
Atopic DermatitisContact Dermatitis
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE
2 shared
PHARMACIA AND UPJOHN
Shared indications:
Atopic DermatitisContact Dermatitis
ZONALON
DOXEPIN HYDROCHLORIDE
2 shared
Viatris
Shared indications:
PruritusAtopic Dermatitis
ADBRY
TRALOKINUMAB
1 shared
LEO PHARMA AS
Shared indications:
Atopic Dermatitis
AMOXAPINE
AMOXAPINE
1 shared
CHARTWELL RX
Shared indications:
Anxiety
ATIVAN
LORAZEPAM
1 shared
BAUSCH
Shared indications:
Anxiety
BYLVAY
ODEVIXIBAT
1 shared
IPSEN
Shared indications:
Pruritus
CARBINOXAMINE MALEATE
CARBINOXAMINE MALEATE
1 shared
MIKART
Shared indications:
Urticaria
CIBINQO
ABROCITINIB
1 shared
Pfizer
Shared indications:
Atopic Dermatitis
CROTAN
CROTAMITON
1 shared
LEGACY PHARMA
Shared indications:
Pruritus
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

HYDROXYZINE PAMOATE FDA Label Details

Pro

Indications & Usage

INDICATIONS For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (Demerol ® ) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloi...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.